{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:35:20Z","timestamp":1787510120889,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejso.2021.09.013","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T02:33:12Z","timestamp":1632105192000},"page":"312-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Health-related quality of life using the FACT-M questionnaire in patients with malignant melanoma: A systematic review"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7932-8233","authenticated-orcid":false,"given":"Ann-Sophie","family":"Lindqvist Bagge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Wesslau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2393-0134","authenticated-orcid":false,"given":"Roza","family":"Cizek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3512-4535","authenticated-orcid":false,"given":"Carl Jacob","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Moncrieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9764-7526","authenticated-orcid":false,"given":"Dimitrios","family":"Katsarelias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Carlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-0355","authenticated-orcid":false,"given":"Roger","family":"Olofsson Bagge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2021.09.013_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Canc"},{"issue":"Suppl 6","key":"10.1016\/j.ejso.2021.09.013_bib2","doi-asserted-by":"crossref","first-page":"vi51","DOI":"10.1093\/annonc\/mdp255","article-title":"A\u00a0systematic review of health-related quality of life in cutaneous melanoma","volume":"20","author":"Cornish","year":"2009","journal-title":"Ann Oncol : official journal of the European Society for Medical Oncology \/ ESMO"},{"key":"10.1016\/j.ejso.2021.09.013_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116440","article-title":"Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study","volume":"10","author":"Beutel","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.ejso.2021.09.013_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bjps.2005.01.010","article-title":"Psychological distress surrounding diagnosis of malignant and nonmalignant skin lesions at a pigmented lesion clinic","volume":"59","author":"Al-Shakhli","year":"2006","journal-title":"J\u00a0Plast Reconstr Aesthetic Surg : JPRAS"},{"key":"10.1016\/j.ejso.2021.09.013_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/CMR.0b013e32834d3da0","article-title":"Health-related quality of life among patients with metastatic melanoma: results from an international phase 2 multicenter study","volume":"22","author":"Robinson","year":"2012","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejso.2021.09.013_bib6","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/cncr.23424","article-title":"Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire","volume":"112","author":"Cormier","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2021.09.013_bib7","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1200\/JCO.1999.17.7.2256","article-title":"Psychosocial predictors of survival in metastatic melanoma","volume":"17","author":"Butow","year":"1999","journal-title":"J\u00a0Clin Oncol : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ejso.2021.09.013_bib8","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/0959-8049(93)90115-V","article-title":"Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma","volume":"29A","author":"Coates","year":"1993","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2021.09.013_bib9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/jdv.15487","article-title":"Quality of life measurement in skin cancer patients: literature review and position paper of the European academy of dermatology and venereology task forces on quality of life and patient oriented outcomes, melanoma and non-melanoma skin cancer","volume":"33","author":"Chernyshov","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejso.2021.09.013_bib10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/cncr.32554","article-title":"Quality-of-life assessment in French patients with metastatic melanoma in real life","volume":"126","author":"Kandel","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2021.09.013_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040751","article-title":"Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic review","volume":"11","author":"Blood","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejso.2021.09.013_bib12","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hec.1608","article-title":"Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data","volume":"19","author":"Devlin","year":"2010","journal-title":"Health Econ"},{"key":"10.1016\/j.ejso.2021.09.013_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00019053-200017010-00002","article-title":"A\u00a0comparative review of generic quality-of-life instruments","volume":"17","author":"Coons","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ejso.2021.09.013_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024454","article-title":"Comparison between different instruments for measuring health-related quality of life in a population sample, the WHO MONICA Project, Gothenburg, Sweden: an observational, cross-sectional study","volume":"9","author":"Krantz","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejso.2021.09.013_bib15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/1740774518795637","article-title":"Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials","volume":"15","author":"Bottomley","year":"2018","journal-title":"Clin Trials"},{"key":"10.1016\/j.ejso.2021.09.013_bib16","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/jamainternmed.2018.4710","article-title":"Evaluating progression-free survival as a surrogate outcome for health-related quality of life in oncology: a systematic review and quantitative analysis","volume":"178","author":"Kovic","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejso.2021.09.013_bib17","first-page":"A71","article-title":"Measuring population health outcomes","volume":"7","author":"Parrish","year":"2010","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.ejso.2021.09.013_bib18","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/jnci\/dji337","article-title":"Reflections on findings of the cancer outcomes measurement working group: moving to the next phase","volume":"97","author":"Gotay","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2021.09.013_bib19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/bmj.324.7351.1417","article-title":"Quality of life measurement: bibliographic study of patient assessed health outcome measures","volume":"324","author":"Garratt","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ejso.2021.09.013_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5502\/ijw.v2i3.4","article-title":"The challenge of defining wellbeing","volume":"2","author":"Dodge","year":"2012","journal-title":"International Journal of Wellbeing"},{"key":"10.1016\/j.ejso.2021.09.013_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1310\/sci2003-167","article-title":"Definitions of quality of life: what has happened and how to move on","volume":"20","author":"Post","year":"2014","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"10.1016\/j.ejso.2021.09.013_bib22","first-page":"139","article-title":"Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale","volume":"3","author":"Cormier","year":"2005","journal-title":"J\u00a0Support Oncol"},{"key":"10.1016\/j.ejso.2021.09.013_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00435223","article-title":"The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique","volume":"2","author":"Sigurdardottir","year":"1993","journal-title":"Qual Life Res : an international journal of quality of life aspects of treatment, care and rehabilitation"},{"key":"10.1016\/j.ejso.2021.09.013_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/07357909309024860","article-title":"Quality of life in cancer: definition, purpose, and method of measurement","volume":"11","author":"Cella","year":"1993","journal-title":"Canc Invest"},{"key":"10.1016\/j.ejso.2021.09.013_bib25","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J\u00a0Clin Oncol : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.ejso.2021.09.013_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-1-79","article-title":"The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation","volume":"1","author":"Webster","year":"2003","journal-title":"Health Qual Life Outcome"},{"key":"10.1016\/j.ejso.2021.09.013_bib27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ejso.2021.09.013_bib28","series-title":"Scientific and medical communication: a guide for effective practice","author":"Mogull","year":"2017"},{"key":"10.1016\/j.ejso.2021.09.013_bib29","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2021.09.013_bib30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12955-018-1047-z","article-title":"Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: a feasibility study","volume":"16","author":"Makady","year":"2018","journal-title":"Health Qual Life Outcome"},{"key":"10.1016\/j.ejso.2021.09.013_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/CMR.0b013e3283511dbf","article-title":"Reducing patient burden to the FACT-Melanoma quality-of-life questionnaire","volume":"22","author":"Swartz","year":"2012","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejso.2021.09.013_bib32","article-title":"Unmet supportive care needs, health status and minimum costs in survivors of malignant melanoma","volume":"27","author":"Davies","year":"2018","journal-title":"Eur J Canc Care"},{"key":"10.1016\/j.ejso.2021.09.013_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2017.4701","article-title":"Sensitivity of preference-based quality-of-life measures for economic evaluations in early-stage melanoma","volume":"154","author":"Dieng","year":"2018","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.ejso.2021.09.013_bib34","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jval.2011.04.003","article-title":"Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights","volume":"14","author":"Askew","year":"2011","journal-title":"Value Health : the journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"key":"10.1016\/j.ejso.2021.09.013_bib35","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1524-4733.2009.00570.x","article-title":"Evaluating minimal important differences for the FACT-Melanoma quality of life questionnaire","volume":"12","author":"Askew","year":"2009","journal-title":"Value Health : the journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"key":"10.1016\/j.ejso.2021.09.013_bib36","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1245\/s10434-016-5103-9","article-title":"Health-related quality of life for patients who have in-transit melanoma metastases treated with isolated limb perfusion","volume":"23","author":"Bagge","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2021.09.013_bib37","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1245\/s10434-019-07375-y","article-title":"Negative sentinel lymph node biopsy in patients with melanoma: the patient's perspective","volume":"26","author":"Banting","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2021.09.013_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/pon.3718","article-title":"Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia","volume":"24","author":"Beesley","year":"2015","journal-title":"Psycho Oncol"},{"key":"10.1016\/j.ejso.2021.09.013_bib39","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1470-2045(15)00087-X","volume":"16","author":"Grob","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2021.09.013_bib40","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1245\/s10434-014-3979-9","article-title":"Quality of life after isolated limb infusion for in-transit melanoma of the extremity","volume":"22","author":"Jiang","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2021.09.013_bib41","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/annonc\/mdu366","article-title":"Prevalence and correlates of unmet supportive care needs in patients with resected invasive cutaneous melanoma","volume":"25","author":"Molassiotis","year":"2014","journal-title":"Ann Oncol : official journal of the European Society for Medical Oncology \/ ESMO"},{"key":"10.1016\/j.ejso.2021.09.013_bib42","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1245\/s10434-018-6470-1","article-title":"1 versus 2-cm excision margins for pT2-pT4 primary cutaneous melanoma (MelMarT): a feasibility study","volume":"25","author":"Moncrieff","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2021.09.013_bib43","first-page":"2155","article-title":"Patient perspectives on ipilimumab across the melanoma treatment trajectory","volume":"25","author":"Shuk","year":"2017","journal-title":"Support Care Canc : official journal of the Multinational Association of Supportive Care in Cancer"},{"key":"10.1016\/j.ejso.2021.09.013_bib44","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/bjd.13262","article-title":"Health-related quality of life in patients with melanoma expressed as utilities and disability weights","volume":"171","author":"Tromme","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejso.2021.09.013_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/CMR.0b013e32835c7dd9","article-title":"The FACT-Melanoma quality-of-life instrument: comparison of a five-point and four-point response scale using the Rasch measurement model","volume":"23","author":"Winstanley","year":"2013","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejso.2021.09.013_bib46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/1744666X.2017.1286984","article-title":"Topical immunotherapy with diphencyprone (DPCP) for in-transit and unresectable cutaneous melanoma lesions: an inaugural Canadian series","volume":"13","author":"Yeung","year":"2017","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.ejso.2021.09.013_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tcmj.2012.09.002","article-title":"Methodological issues in measuring health-related quality of life","volume":"25","author":"Lin","year":"2013","journal-title":"Tzu Chi Med J"},{"key":"10.1016\/j.ejso.2021.09.013_bib48","unstructured":"FACIT group. .FACT-M scoring guidelines (version 4). editor\u2227, editors\". City."},{"key":"10.1016\/j.ejso.2021.09.013_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12957-019-1663-z","article-title":"Surgery for gastrointestinal metastases of malignant melanoma - a retrospective exploratory study","volume":"17","author":"Holmberg","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2021.09.013_bib50","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0643","article-title":"Association of disease progression with health-related quality of life among adults with breast, lung, pancreatic, and colorectal cancer","volume":"3","author":"Marschner","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2021.09.013_bib51","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/cncr.33483","article-title":"Active surveillance of patients who have sentinel node positive melanoma: an international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)","volume":"127","author":"Broman","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2021.09.013_bib52","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2021.09.013_bib53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/02841860310023453","article-title":"Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivors","volume":"43","author":"Holzner","year":"2004","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejso.2021.09.013_bib54","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/pon.1428","article-title":"The queensland cancer risk study: general population norms for the functional assessment of cancer therapy-general (FACT-G)","volume":"18","author":"Janda","year":"2009","journal-title":"Psycho Oncol"},{"key":"10.1016\/j.ejso.2021.09.013_bib55","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12955-020-01420-1","article-title":"Health-related quality of life (FACT-GP) in Sweden","volume":"18","author":"Lindqvist Bagge","year":"2020","journal-title":"Health Qual Life Outcome"},{"key":"10.1016\/j.ejso.2021.09.013_bib56","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s11136-019-02214-9","article-title":"A\u00a0systematic review of quality of life research in medicine and health sciences","volume":"28","author":"Haraldstad","year":"2019","journal-title":"Qual Life Res"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321007393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321007393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:41:01Z","timestamp":1760060461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798321007393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0748798321007393"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2021.09.013","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-related quality of life using the FACT-M questionnaire in patients with malignant melanoma: A systematic review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2021.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}